Radboudumc Taskforce Genetic Therapy: Guus van den Akker

Genome engineering of primary mesenchymal stem cells using CRISPR/Cas9

Date:
29 March 2016 17:00 hrs. - 17:45 hrs.
Location:
Location see remarks
Title:
Genome engineering of primary mesenchymal stem cells using CRISPR/Cas9
Speaker(s):

Guus van den Akker, Dept. of Experimental Rheumatology, RIMLS

Host(s):

Rob Collin, Dept. of Human Genetics, Radboudumc

29-03-2016 17:00:0029-03-2016 17:45:00Europe/AmsterdamGenome engineering of primary mesenchymal stem cells using CRISPR/Cas9 Location see remarksRimlsrimls@radboudumc.nl

Remarks / more information:


Location:
 Demonstration room, Pathology, route 828 

undefined

Photo: Guus van den Akker. 

The Radboudumc Taskforce Genetic Therapy (RTGT) is dedicated to “Stimulate the implementation of genetic therapy within the Radboudumc”. We want to achieve this by bundling activities in fundamentally oriented and clinical research, and by exchanging knowledge & expertise via our bi-monthly RTGT meetings. These meetings are open to all that are interested.  

For more information, please contact Rob Collin (Dept. of Human Genetics), rob.collin@radboudumc.nl



<< back to all events